Exclusive

Publication

Byline

Location

US Patent Issued to The Children's Hospital of Philadelphia on Sept. 8 for "Net stabilization as a therapy for sepsis" (Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,153, issued on Sept. 8, was assigned to The Children's Hospital of Philadelphia (Philadelphia). "Net stabilization as a therapy for sepsis"... Read More


US Patent Issued to EXOLLENCE, EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION on Sept. 8 for "Exosomes comprising coronavirus-derived antigen protein or gene encoding same protein, and use of same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,154, issued on Sept. 8, was assigned to EXOLLENCE Co. LTD. (Seoul, South Korea) and EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (Seoul... Read More


US Patent Issued to The University of Chicago, Anokion on Sept. 8 for "Compositions and methods for inducing immune tolerance" (Illinois, Maryland, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,155, issued on Sept. 8, was assigned to The University of Chicago (Chicago) and Anokion SA (Ecublens, Switzerland). "Compositions and metho... Read More


US Patent Issued to Regents of the University of Minnesota on Sept. 8 for "Tumor cell-derived exosomes and method of treating colorectal cancer" (Minnesota Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,156, issued on Sept. 8, was assigned to Regents of the University of Minnesota (Minneapolis). "Tumor cell-derived exosomes and method of tr... Read More


US Patent Issued to CIRCULAR BIOTECH on Sept. 8 for "Autologous cancer tumour associated extrachromosomal circular DNA for use as a therapeutic vaccine" (Swedish Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,157, issued on Sept. 8, was assigned to CIRCULAR BIOTECH AB (Umea, Sweden). "Autologous cancer tumour associated extrachromosomal circular ... Read More


US Patent Issued to KRIPTIC PHARMACEUTICALS on Sept. 8 for "Combination of markers for predicting the response to Vx-001" (French Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,158, issued on Sept. 8, was assigned to KRIPTIC PHARMACEUTICALS Ltd. (Dublin). "Combination of markers for predicting the response to Vx-00... Read More


US Patent Issued to LOYOLA UNIVERSITY OF CHICAGO, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE on Sept. 8 for "Coronavirus vaccines compositions and method of using same" (Illinois, Iowa Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,159, issued on Sept. 8, was assigned to LOYOLA UNIVERSITY OF CHICAGO (Chicago) and THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRE... Read More


US Patent Issued to FluGen on Sept. 8 for "Vaccine using M2/BM2-deficient influenza vectors" (Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,160, issued on Sept. 8, was assigned to FluGen Inc. (Madison, Wis.). "Vaccine using M2/BM2-deficient influenza vectors" was invented by Mic... Read More


US Patent Issued to CORNELL UNIVERSITY on Sept. 8 for "Use of membrane inhibitors to enhance vaccine development against enveloped viruses" (New York Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,161, issued on Sept. 8, was assigned to CORNELL UNIVERSITY (Ithaca, N.Y.). "Use of membrane inhibitors to enhance vaccine development again... Read More


US Patent Issued to Genentech on Sept. 8 for "Methods of treating lung cancer with a PD-1 axis binding antagonist, a platinum agent, and a topoisomerase II inhibitor" (American, Swiss Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,162, issued on Sept. 8, was assigned to Genentech Inc. (South San Francisco, Calif.). "Methods of treating lung cancer with a PD-1 axis bin... Read More